MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
38.54
-1.64 (-4.08%)
May 13, 2025, 4:00 PM - Market closed

MLTX Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
271.57180.43451.1739.518.04
Short-Term Investments
208.56267.659.8432.61-
Cash & Short-Term Investments
480.13448.03511.0172.118.04
Cash Growth
-12.23%-12.32%608.60%797.08%-
Other Receivables
2.992.841.060.220.15
Receivables
2.992.841.060.220.15
Prepaid Expenses
23.1523.422.14.181.45
Total Current Assets
506.26474.29514.1776.519.64
Property, Plant & Equipment
3.33.643.950.330.05
Other Long-Term Assets
1.7-8.42--
Total Assets
511.26477.93526.5476.849.68
Accounts Payable
12.010.220.330.160.03
Accrued Expenses
10.5420.238.077.244.76
Short-Term Debt
----15
Current Portion of Leases
1.431.371.20.15-
Current Income Taxes Payable
-0.640.370.110.06
Other Current Liabilities
----1.23
Total Current Liabilities
23.9822.469.977.6721.09
Long-Term Leases
1.141.462.50.13-
Total Liabilities
98.6824.5413.058.0821.33
Common Stock
0.010.010.010.010.04
Additional Paid-In Capital
680.66677.41609.97129.1942.06
Retained Earnings
-275.54-235.59-116.66-80.65-53.64
Treasury Stock
-----0.01
Comprehensive Income & Other
2.3952.360.35-0.17
Total Common Equity
407.52446.83495.6848.9-11.72
Minority Interest
5.066.5717.8219.87-
Shareholders' Equity
412.58453.39513.4968.77-11.65
Total Liabilities & Equity
511.26477.93526.5476.849.68
Total Debt
75.62.833.70.2815
Net Cash (Debt)
404.53445.2507.3171.83-6.96
Net Cash Growth
-25.55%-12.24%606.24%--
Net Cash Per Share
6.427.0810.332.45-0.89
Filing Date Shares Outstanding
63.4763.2862.8739.150.3
Total Common Shares Outstanding
63.4763.0860.4738.980.3
Working Capital
482.28451.82504.268.85-11.45
Book Value Per Share
6.427.088.201.25-38.57
Tangible Book Value
407.52446.83495.6848.9-11.72
Tangible Book Value Per Share
6.427.088.201.25-38.57
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q